The world’s ever-growing elderly population is leading to a rise in prevalence of ‘diseases of aging’, like sarcopenia. Nutritious meals and fortified foods are recommended in the first instance to achieve the best possible nutritional care in individuals with complex needs as a result of a mobility condition. But what if these solutions aren’t enough to achieve the required amounts of essential nutrients?
Medical nutrition solutions can help to support individuals experiencing mobility issues, like sarcopenia. Download our guide to discover why taking a condition-specific approach to medical nutrition innovation enables manufacturers to develop targeted, effective and appealing products that address the special nutritional requirements present in the elderly community.
Sarcopenia, a progressive and generalized skeletal muscle disorder that involves the accelerated loss of muscle mass and function, affects between 10-40% of adults over the age of 70. Support the growing number of elderly people with mobility conditions, like sarcopenia, by offering optimized medical nutrition solutions.
Preserving muscle health and decreasing the risk of muscle loss is becoming increasingly relevant as the number of sarcopenia and cancer cachexia cases rise worldwide. This whitepaper outlines the emerging role of the omega-3 fatty acids EPA and DHA in supporting individuals experiencing muscle loss as the result of aging or disease.